Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.

Gantt S, Kakuru A, Wald A, Walusansa V, Corey L, Casper C, Orem J.

Pediatr Blood Cancer. 2010 May;54(5):670-4. doi: 10.1002/pbc.22369.

PMID:
20205254
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.

Phipps W, Ssewankambo F, Nguyen H, Saracino M, Wald A, Corey L, Orem J, Kambugu A, Casper C.

PLoS One. 2010 Nov 12;5(11):e13936. doi: 10.1371/journal.pone.0013936.

PMID:
21103057
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Treatment of Kaposi sarcoma in children with HIV-1 infection.

Anglemyer A, Agrawal AK, Rutherford GW.

Cochrane Database Syst Rev. 2014 Jan 27;1:CD009826. doi: 10.1002/14651858.CD009826.pub2. Review.

PMID:
24464843
[PubMed - indexed for MEDLINE]
4.

Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.

Cox CM, El-Mallawany NK, Kabue M, Kovarik C, Schutze GE, Kazembe PN, Mehta PS.

Pediatr Blood Cancer. 2013 Aug;60(8):1274-80. doi: 10.1002/pbc.24516. Epub 2013 Mar 11.

PMID:
23487320
[PubMed - indexed for MEDLINE]
5.

Kaposi sarcoma in South African children.

Stefan DC, Stones DK, Wainwright L, Newton R.

Pediatr Blood Cancer. 2011 Mar;56(3):392-6. doi: 10.1002/pbc.22903. Epub 2010 Nov 28.

PMID:
21225916
[PubMed - indexed for MEDLINE]
6.

Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.

Letang E, Almeida JM, Miró JM, Ayala E, White IE, Carrilho C, Bastos R, Nhampossa T, Menéndez C, Campbell TB, Alonso PL, Naniche D.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):589-97. doi: 10.1097/QAI.0b013e3181bc476f.

PMID:
19801945
[PubMed - indexed for MEDLINE]
7.

Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.

Asiimwe F, Moore D, Were W, Nakityo R, Campbell J, Barasa A, Mermin J, Kaharuza F.

HIV Med. 2012 Mar;13(3):166-71. doi: 10.1111/j.1468-1293.2011.00955.x. Epub 2011 Nov 24.

PMID:
22112164
[PubMed - indexed for MEDLINE]
8.

Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.

Ziegler JL, Katongole-Mbidde E.

Int J Cancer. 1996 Jan 17;65(2):200-3.

PMID:
8567117
[PubMed - indexed for MEDLINE]
9.

Gingival involvement in a case series of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.

Kalpidis CD, Lysitsa SN, Lombardi T, Kolokotronis AE, Antoniades DZ, Samson J.

J Periodontol. 2006 Mar;77(3):523-33.

PMID:
16512768
[PubMed - indexed for MEDLINE]
10.

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.

Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, De Cock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, Reeves G, Weiss R, Beral V.

AIDS. 1997 Nov;11(13):1619-26.

PMID:
9365767
[PubMed - indexed for MEDLINE]
11.

Kaposi's sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children.

Amir H, Kaaya EE, Manji KP, Kwesigabo G, Biberfeld P.

Pediatr Infect Dis J. 2001 May;20(5):518-21.

PMID:
11368110
[PubMed - indexed for MEDLINE]
12.

Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.

Speicher DJ, Sehu MM, Johnson NW, Shaw DR.

J Clin Virol. 2013 Jul;57(3):282-5. doi: 10.1016/j.jcv.2013.03.005. Epub 2013 Apr 8.

PMID:
23578530
[PubMed - indexed for MEDLINE]
13.

Prevalence and outcome of HIV-associated malignancies among children.

Tukei VJ, Kekitiinwa A, Beasley RP.

AIDS. 2011 Sep 10;25(14):1789-93. doi: 10.1097/QAD.0b013e3283498115.

PMID:
21673560
[PubMed - indexed for MEDLINE]
14.

Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.

Gill J, Bourboulia D, Wilkinson J, Hayes P, Cope A, Marcelin AG, Calvez V, Gotch F, Boshoff C, Gazzard B.

J Acquir Immune Defic Syndr. 2002 Dec 1;31(4):384-90.

PMID:
12447008
[PubMed - indexed for MEDLINE]
15.

Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.

Borok M, Fiorillo S, Gudza I, Putnam B, Ndemera B, White IE, Gwanzura L, Schooley RT, Campbell TB.

Clin Infect Dis. 2010 Aug 1;51(3):342-9. doi: 10.1086/654800.

PMID:
20572760
[PubMed - indexed for MEDLINE]
Free Article
16.

Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children.

Athale UH, Patil PS, Chintu C, Elem B.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):96-100.

PMID:
8548353
[PubMed - indexed for MEDLINE]
17.

Oral HIV-associated Kaposi sarcoma.

Pantanowitz L, Khammissa RA, Lemmer J, Feller L.

J Oral Pathol Med. 2013 Mar;42(3):201-7. doi: 10.1111/j.1600-0714.2012.01180.x. Epub 2012 Jun 5. Review.

PMID:
22672182
[PubMed - indexed for MEDLINE]
18.

Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.

Cattelan AM, Calabrò ML, Gasperini P, Aversa SM, Zanchetta M, Meneghetti F, De Rossi A, Chieco-Bianchi L.

J Natl Cancer Inst Monogr. 2001;(28):44-9.

PMID:
11158206
[PubMed - indexed for MEDLINE]
19.
20.

Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.

El Amari EB, Toutous-Trellu L, Gayet-Ageron A, Baumann M, Cathomas G, Steffen I, Erb P, Mueller NJ, Furrer H, Cavassini M, Vernazza P, Hirsch HH, Bernasconi E, Hirschel B; Swiss HIV Cohort Study.

AIDS. 2008 May 31;22(9):1019-28. doi: 10.1097/QAD.0b013e3282fc9c03.

PMID:
18520345
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk